Acute Granulocytic Leukemia in Elderly Patients

Clara D. Bloomfield, Athanasios Theologides

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We reviewed 134 cases of acute granulocytic leukemia in adult patients in three age groups. There were no differences among groups in the nature of onset, initial physical findings, morphologic characteristics, hematologic indices, complications, causes of death, or survival. While patients under 40 years responded more frequently to vigorous chemotherapy, responders over 60 years had equally long remissions and survivals. Patients aged 41 to 60 and 61 to 86 responded equally well. Prospective studies of vigorous chemotherapy in elderly patients with acute leukemia are warranted.

Original languageEnglish (US)
Pages (from-to)1190-1193
Number of pages4
JournalJAMA: The Journal of the American Medical Association
Volume226
Issue number10
DOIs
StatePublished - Dec 3 1973

Fingerprint

Myeloid Leukemia
Drug Therapy
Survival
Cause of Death
Leukemia
Age Groups
Prospective Studies

Cite this

Acute Granulocytic Leukemia in Elderly Patients. / Bloomfield, Clara D.; Theologides, Athanasios.

In: JAMA: The Journal of the American Medical Association, Vol. 226, No. 10, 03.12.1973, p. 1190-1193.

Research output: Contribution to journalArticle

Bloomfield, Clara D. ; Theologides, Athanasios. / Acute Granulocytic Leukemia in Elderly Patients. In: JAMA: The Journal of the American Medical Association. 1973 ; Vol. 226, No. 10. pp. 1190-1193.
@article{3b790f96418949c58e3cda89d4164ee2,
title = "Acute Granulocytic Leukemia in Elderly Patients",
abstract = "We reviewed 134 cases of acute granulocytic leukemia in adult patients in three age groups. There were no differences among groups in the nature of onset, initial physical findings, morphologic characteristics, hematologic indices, complications, causes of death, or survival. While patients under 40 years responded more frequently to vigorous chemotherapy, responders over 60 years had equally long remissions and survivals. Patients aged 41 to 60 and 61 to 86 responded equally well. Prospective studies of vigorous chemotherapy in elderly patients with acute leukemia are warranted.",
author = "Bloomfield, {Clara D.} and Athanasios Theologides",
year = "1973",
month = "12",
day = "3",
doi = "10.1001/jama.1973.03230100022007",
language = "English (US)",
volume = "226",
pages = "1190--1193",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Acute Granulocytic Leukemia in Elderly Patients

AU - Bloomfield, Clara D.

AU - Theologides, Athanasios

PY - 1973/12/3

Y1 - 1973/12/3

N2 - We reviewed 134 cases of acute granulocytic leukemia in adult patients in three age groups. There were no differences among groups in the nature of onset, initial physical findings, morphologic characteristics, hematologic indices, complications, causes of death, or survival. While patients under 40 years responded more frequently to vigorous chemotherapy, responders over 60 years had equally long remissions and survivals. Patients aged 41 to 60 and 61 to 86 responded equally well. Prospective studies of vigorous chemotherapy in elderly patients with acute leukemia are warranted.

AB - We reviewed 134 cases of acute granulocytic leukemia in adult patients in three age groups. There were no differences among groups in the nature of onset, initial physical findings, morphologic characteristics, hematologic indices, complications, causes of death, or survival. While patients under 40 years responded more frequently to vigorous chemotherapy, responders over 60 years had equally long remissions and survivals. Patients aged 41 to 60 and 61 to 86 responded equally well. Prospective studies of vigorous chemotherapy in elderly patients with acute leukemia are warranted.

UR - http://www.scopus.com/inward/record.url?scp=0015761389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015761389&partnerID=8YFLogxK

U2 - 10.1001/jama.1973.03230100022007

DO - 10.1001/jama.1973.03230100022007

M3 - Article

VL - 226

SP - 1190

EP - 1193

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 10

ER -